B
Bradford R. Hirsch
Researcher at Durham University
Publications - 45
Citations - 2076
Bradford R. Hirsch is an academic researcher from Durham University. The author has contributed to research in topics: Clinical trial & Health care. The author has an hindex of 19, co-authored 45 publications receiving 1842 citations. Previous affiliations of Bradford R. Hirsch include Duke University.
Papers
More filters
Journal ArticleDOI
Delivering affordable cancer care in high-income countries
Richard Sullivan,Jeffrey Peppercorn,Karol Sikora,John Zalcberg,Neal J. Meropol,Eitan Amir,David Khayat,Peter Boyle,Philippe Autier,Ian F. Tannock,Tito Fojo,Jim Siderov,Steve Williamson,Silvia Camporesi,J. Gordon McVie,Arnie Purushotham,Peter Naredi,Alexander M.M. Eggermont,Murray F. Brennan,Michael L. Steinberg,Mark De Ridder,Susan A. McCloskey,Dirk Verellen,Terence Roberts,Guy Storme,Rodney J. Hicks,Peter J. Ell,Bradford R. Hirsch,David P. Carbone,Kevin A. Schulman,Paul Catchpole,David Taylor,Jan Geissler,Nancy G Brinker,David O. Meltzer,David J. Kerr,Matti Aapro +36 more
TL;DR: Urgent solutions range from re-engineering of the macroeconomic basis of cancer costs (eg, value-based approaches to bend the cost curve and allow cost-saving technologies), greater education of policy makers, and an informed and transparent regulatory system.
Journal ArticleDOI
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
John F. Cryan,Olivia F. O’Leary,Sung-Ha Jin,Julie C. Friedland,Ming Ouyang,Bradford R. Hirsch,Michelle E. Page,Ashutosh Dalvi,Steven A. Thomas,Irwin Lucki +9 more
TL;DR: Restoration of NE by using L-threo-3,4-dihydroxyphenylserine reinstated the behavioral effects of both desipramine and paroxetine in Dbh(-/-) mice, thus demonstrating that the reduced sensitivity to antidepressants is related to NE function, as opposed to developmental abnormalities resulting from chronic NE deficiency.
Journal ArticleDOI
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov.
Bradford R. Hirsch,Robert M. Califf,Steven K. Cheng,Asba Tasneem,John R. Horton,Karen Chiswell,Kevin A. Schulman,David M. Dilts,Amy P. Abernethy +8 more
TL;DR: There are significant variations between clinical trials in oncology and other diseases, as well as among trials within oncologists, and the differences must be better understood to improve both the impact of cancer research on clinical practice and the use of constrained resources.
Journal ArticleDOI
Surgical Prehabilitation in Patients with Cancer: State-of-the-Science and Recommendations for Future Research from a Panel of Subject Matter Experts
Francesco Carli,Julie K. Silver,Liane S. Feldman,Andrea B. McKee,Sean Gilman,Chelsia Gillis,Celena Scheede-Bergdahl,Ann Gamsa,Nicole L. Stout,Bradford R. Hirsch +9 more
TL;DR: The panel focused on the current state of the science and recommended future research that would help to identify the elements that enhance preoperative physical, nutritional, and psychological health in anticipation of surgery, mitigate the burden of disease, facilitate the return of patient health status to baseline values, decrease postoperative morbidity, and reduce health care costs.
Journal Article
Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
TL;DR: Biochemical studies showed that there was no significant difference in the regional brain levels of NE transporter immunoreactivity or monoamine oxidase activity, the primary targets for most of the compounds examined.